Abaxis (Nasdaq: ABAX) reported earnings on Oct. 23. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q2), Abaxis met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew and GAAP earnings per share expanded significantly.

Gross margins dropped, operating margins dropped, net margins increased.

Revenue details
 Abaxis logged revenue of $44.3 million. The eight analysts polled by S&P Capital IQ wanted to see revenue of $44.6 million on the same basis. GAAP reported sales were 11% higher than the prior-year quarter's $40.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.18. The eight earnings estimates compiled by S&P Capital IQ predicted $0.18 per share. GAAP EPS of $0.58 for Q2 were 287% higher than the prior-year quarter's $0.15 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 52.2%, 280 basis points worse than the prior-year quarter. Operating margin was 7.7%, 520 basis points worse than the prior-year quarter. Net margin was 29.2%, 2,090 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $45.0 million. On the bottom line, the average EPS estimate is $0.19.

Next year's average estimate for revenue is $181.4 million. The average EPS estimate is $0.75.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 160 members out of 176 rating the stock outperform, and 16 members rating it underperform. Among 44 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 41 give Abaxis a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Abaxis is outperform, with an average price target of $40.93.